Complete LCAT deficiency uniformly results in a profound HDL deficiency. We recently reported unexpected enhanced insulin sensitivity in LCAT knockout mice in the LDL receptor knockout background (Ldlr-/-xLcat-/-; DKO), when compared to their Ldlr-/-xLcat+/+ (SKO) controls. Here, we report that LCAT deficient mice (DKO and Lcat-/-) are protected against high fat high sucrose (HFHS) diet-induced obesity without hypophagia in a gender-specific manner compared to their respective (SKO and WT) controls. The metabolic phenotypes are more pronounced in the females. Changes in endoplasmic reticulum (ER) stress were examined as a possible mechanism for the metabolic protection. The female DKO mice developed attenuated HFHSinduced ER stress as evidenced by a lack of increase in mRNA levels of the hepatic unfolded protein response (UPR) markers Grp78 and CHOP compared to SKO controls. The DKO female mice were also protected against diet-induced insulin resistance(IR). In white adipose tissue of chow fed DKO mice, we also observed a reduction in UPR, gene markers for adipogenesis and markers for activation of Wnt signaling. In skeletal muscle of female DKO mice, we observed an unexpected increase in UCP1 in association with increase in phospho-AMPKα, PGC1α and UCP3 expressions. This increase in UCP1 was associated with an ectopic islands of brown adipocytes between skeletal muscle fibers. Our findings suggest that LCAT deficiency confers gender-specific protection against diet-induced obesity and IR at least in part through regulation in UPR, white adipose tissue adipogenesis and brown adipocyte partitioning.
Complete LCAT deficiency uniformly results in a profound HDL deficiency. We recently reported unexpected enhanced insulin sensitivity in LCAT knockout mice in the LDL receptor knockout background (Ldlr-/-xLcat-/-; DKO), when compared to their Ldlr-/-xLcat+/+ (SKO) controls. Here, we report that LCAT deficient mice (DKO and Lcat-/-) are protected against high fat high sucrose (HFHS) diet-induced obesity without hypophagia in a gender-specific manner compared to their respective (SKO and WT) controls. The metabolic phenotypes are more pronounced in the females. Changes in endoplasmic reticulum (ER) stress were examined as a possible mechanism for the metabolic protection. The female DKO mice developed attenuated HFHSinduced ER stress as evidenced by a lack of increase in mRNA levels of the hepatic unfolded protein response (UPR) markers Grp78 and CHOP compared to SKO controls. The DKO female mice were also protected against diet-induced insulin resistance(IR). In white adipose tissue of chow fed DKO mice, we also observed a reduction in UPR, gene markers for adipogenesis and markers for activation of Wnt signaling. In skeletal muscle of female DKO mice, we observed an unexpected increase in UCP1 in association with increase in phospho-AMPKα, PGC1α and UCP3 expressions. This increase in UCP1 was associated with an ectopic islands of brown adipocytes between skeletal muscle fibers. Our findings suggest that LCAT deficiency confers gender-specific protection against diet-induced obesity and IR at least in part through regulation in UPR, white adipose tissue adipogenesis and brown adipocyte partitioning.
LCAT is an important enzyme in the regulation of HDL metabolism and in modulating plasma HDL-cholesterol levels. LCAT mediates the esterification of cholesterol primarily in HDL but also to a limited extent in low density lipoproteins (LDL). Familial complete LCAT deficiency in humans is characterized by extremely low levels of plasma HDL-C. In addition, commonly observed lipid phenotypes include elevated plasma level of phospholipid, free cholesterol (FC) to cholesterol ester (CE) ratio and modest hypertriglyceridemia (HTG), the latter characterized by combined hepatic TG overproduction and partially reduced lipoprotein lipase activity (1, 2) . Recent human studies in a large cohort of subjects with familial LCAT deficiencies suggest that low LCAT may protect against atherosclerosis (3) . However, studies in subjects with low LCAT in the general population yielded conflicting results (4) . On the other hand, the potential role for LCAT in the modulation of glucose and energy homeostasis has received little attention. Our laboratory was the first to report that, in the LDL receptor knockout mouse background and under chow fed condition, genetic absence of LCAT (Ldlr-/-xLcat-/-mice) is associated with enhanced insulin sensitivity when compared with the Ldlr-/-xLcat+/+ control mice (4, 5) . The impact of these novel phenotypes in response to obesogenic and diabetogenic stresses remains to be fully elucidated.
It has recently been shown that hepatic and adipose tissue endoplasmic reticulum (ER) stress play an important role in the development of insulin resistance. In both HFHS diet-induced and leptin-deficient genetic (ob/ob) models of obesity and insulin resistance, expression of the unfolded protein response (UPR) has been shown to be upregulated in both the liver and adipose tissue, but not skeletal muscle (6) .
Although the mechanism of activation of UPR in these two models is not well understood, treatment of these obese models with the small molecule chaperone phenylbutyrate led to rapid resolution of insulin resistance even prior to any significant weight loss (7) . In humans, ER stress has been demonstrated in adipose tissue in obese, insulin resistant nondiabetic subjects (8, 9) . More recently, Gregor et al reported significant reduction in a number of ER stress markers in liver and adipose tissues in subjects who lost weight in response to gastric lap banding operations (10).
Alternations in ER stress has been linked to adipogenesis in white fat. In 3T3L1 cells, palmitate treatment induces preadipocyte ER stress with concomitant inhibition of the canonical Wnt signaling pathway (11), the latter pathway being known to inhibit adipogenesis through activation and nuclear localization of β-catenin. Basseri et al recently reported that resolution of ER stress in 3T3L1 preadipocytes through chemical chaperone treatment inhibits adipogenesis (12) although the role of Wnt signaling was not examined.
Skeletal muscle is a major organ involved in not only insulin stimulated glucose uptake, it is also a major organ in fatty acid oxidation as well as thermogenesis.
PGC1α in skeletal muscle has been shown to play critical roles in (a) stimulating thermogenesis; (b) activating genes in oxidative phosphorylation; (c) stimulating mitochondrial biogenesis and (d) activating GLUT4 expression (13) . Patho-physiologically, skeletal muscle PGC1α mRNA expression is down-regulated along with a panel of genes in mitochondrial oxidative phosphorylation in humans with IR or diabetes (14) as well as in rodent models of obesity, IR and/or diabetes, (15, 16) . A modest tissue specific over-expression of PGC1α in skeletal muscle showed favorable metabolic changes (17) which include increase in mitochondrial biogenesis, expression of FAT/CD36, GLUT4 and AMPKα2 and insulin sensitivity.
Uncoupling protein 3 (UCP3), like UCP1, is a member of the mitochondrial anion carrier protein family which is expressed highly and selectively in skeletal muscle. However, recent studies suggest that the major metabolic function of UCP3 is that of facilitating fatty acid transport and oxidation (18, 19) .
UCP1 is predominantly expressed in brown adipose tissue and it is regarded as the only bona fide uncoupling protein (20) . Brown adipose tissue share the same lineage as skeletal muscle and it has been shown that PRDM16 serves as a key switch between skeletal muscle or brown fat development from the Myf5 positive progenitor cells (21, 22) . UCP1 also express in white adipose tissues under specific conditions. Ectopic brown adipose like cells expressing Ucp1 in skeletal muscle was recently reported in the 129S6/SvEvTac inbred strain, putatively accounting for the relative protection from obesity, hyperglycemia and insulin resistance (23) . The lineage origin of the ectopic brown fat has not been established. Presence of UCP1 expression in WAT can be achieved through transdifferentiation of WAT into brown fat-like adipose tissue, most notably under cold exposure or direct β3 adrenergic stimulation (24) . A recent study by Seale et al showed that expression of PRDM16 in selective WAT depots can generate a brown adipogenic program, expressing Ucp1 and Pdrm 16 (25) .
Here we expand our investigation to whether LCAT deficient mice are also protected against diet-induced obesity and to explore the underlying mechanisms. We examined the effect of LCAT deficiency in both the LDLR knockout and in the wild type background treated with both chow and the obesogenic and diabetogenic high fat high sucrose (HFHS) diet to further elucidate the direct role of LCAT in these phenotypes. We hypothesize that hepatic ER stress plays a contributory role to the observed metabolic phenotypes and we also provide evidence for presence of ectopic, Ucp1 expressing brown adipose tissue in the skeletal muscle of the LCAT deficient mice.
Experimental Procedures
Animals-C57Bl/6 mice and Ldlr-/-mice in C57Bl/6 background were acquired from Jackson Laboratories. As reported earlier, Lcat-/-mice were backcrossed with C57Bl/6 females for more than seven generations (26) . Ldlr-/-mice crossed with Lcat-/-mice generated double heterozygous offspring, Ldlr+/-×Lcat+/-, which were then crossbred to create Ldlr-/-×Lcat-/-doubleknockout (DKO) mice. Controls used were Ldlr-/-×Lcat+/+ mice and the C57Bl/6 wild-type mice (WT). All mice used were age-and gendermatched and fed a regular chow diet or a high fat high sucrose diet (Bio-Serv #F3282, NJ, Ozcan 2004). Chow-fed studies were carried out for mice at 12-14 weeks or 24-26 weeks of age. HFHS dietfed studies were carried out after 24-week or 42-week diet treatment, beginning at 9 weeks of age. The experimental procedures used were approved by the Animal Care Committee at St. Michael's Hospital. All mice were fasted overnight before being sacrificed. The liver samples were flashfrozen in liquid nitrogen and stored at -80 o C. Plasma lipid analyses-Plasma lipid analyses were performed on mice after 24-26 weeks of HFHSdiet treatment. Samples were obtained after an overnight fast and pooled for analysis for total cholesterol, triglycerides, glycerol (to allow for correction of the triglyceride values), free cholesterol and choline phospholipids as previously described (27) . mRNA quantitation of hepatic, adipose tissues and skeletal muscle genes -RNA was extracted from the liver, white adipose and brown adipose tissues and skeletal muscle using Trizol (Invitrogen, Burlington, ON) as described previously (5) For real-time PCR analysis, RNA was reverse transcribed using QuantiTect Reverse transcription kit following the manufacturer's protocol (Qiagen, Mississauga) and SYBR Green PCR master mix (Applied Biosystems, Foster City, CA) was used in quantitatitive PCR reaction and was conducted in the ABI PRISM machine, "7900HT Sequence Detection System" operated with the respective SDS software, version 2.1. Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was used as an internal control.Specific primers were synthesized based on mouse cDNA sequences from GenBank. Primer pairs used to amplify these genes were as follows (forward and reverse, respectively): Grp78 5'-tcagcatcaagcaaggattg, 3 4 , 0.25 mol/l sucrose, and 1 mmol/l EDTA, pH 7.4. A protease inhibitor cocktail (Sigma, Oakville, ON) was added and the sample was homogenized. The homogenate was then centrifuged for 15 min at 12,000 g (4°C) to remove cell debris. Protein concentrations in the supernatant were determined using the MicroBCA Protein Assay Kit (Pierce, Rockford), using the manufacturer's suggested protocol. Grp78, phospho-Perk and phospho-eif2α mass levels were analyzed and β-actin was used as the internal control. Rabbit polyclonal anti-Grp78, anti-phospho-Perk and anti-phospho-eif2α antibodies were purchased from Cell Signaling Technology (New England Biolabs, Pickering, ON). Protein (100 µg) was analyzed after suspension in 2X SDS loading buffer (120mM Tris-HCL, pH 6.8, 20% glycerol, 4% SDS, 4% 2-mercaptoethanol and 0.02%bromophenol blue) and the samples were denatured at 95°C for 5 min. Proteins were separated by 8% SDS-PAGE, which was run at constant voltage of 120V for 2 hours. Proteins were then transferred to a nitrocellulose membrane. The membrane was washed with TBST (10 mM Tris-HCl, pH 7.6, 0.15 M NaCl, 0.1% Tween 20) 3 times for 5 minutes each and blocked for 1 hour with TBST buffer containing 5% skim milk. The membranes were then incubated with antibodies to Grp78 (1:1000 dilution), phospho-Perk (1:1000 dilution), phospho-eif2α (1:1000 dilution) and β -actin membranes were rinsed with TBST buffer followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG (1:3000 dilution) for 1 h (Cayman Chemicals, Burlington, ON). The membranes were treated with Amersham ECL Western Blotting Detection Reagents for visualization of the bands. Quantitative densitometry of immunoblots was performed and the relative content of each sample protein was calculated based on the relative optical density value after normalizing by the optical density value of the internal control. Western blot analysis of skeletal muscle proteinsAfter an overnight fast, mice were sacrificed and quadriceps muscles immediately dissected and snap frozen in liquid N 2 . RNA and protein extractions were carried out as described above. Western blot analysis of fat depot proteins-After an overnight fast, mice were sacrificed and fat tissues from specific depots: interscapular brown adipose tissue (iBAT), subcutaneous white adipose tissue (sWAT), inguinal WAT (ingWAT) and epididymal WAT (eWAT) were immediately dissected and snap frozen in liquid N 2 . RNA and protein extractions were carried out as described above.
Anti-Ucp1 was purchased from Calbiochem (Mississauga Ontario, Canada). Secondary antibody was used as described above. Glucose tolerance test (ipGTT)-After an overnight fast, serial plasma glucose levels were determined by glucometer after an intraperitoneal bolus injection of glucose at 1.125 g/kg body weight as previously described (28) . Insulin tolerance test (ipITT)-After a six-hour fast, study mice were subject to ipITT as previously described (5) . Indirect calorimetry-Metabolic rate of mice was measured by indirect calorimetry in open-circuit oxymax chambers of the Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH). Mice were housed singly and maintained at 23°C under a 12:12-hour light-dark cycle. Food and water were available ad libitum. All mice were acclimatized to monitoring cages for 24 hours prior to the beginning of an additional 78 hours of continuous recordings of physiological parameters. Mice were weighed prior to each trial. Sample air was passed through an oxygen (O 2 ) sensor (Columbus Instruments) for determination of O 2 content. VO 2 and VCO 2 were determined. Analyses were performed using the CLAX software as supplied by the manufacturer. Respiratory Exchange Ratio (RER) was calculated as VCO 2 /VO 2 , heat production was calculated as VO 2 x [3.815 + 1.232xRER]. Activity was determined by sum of X-axis and Z-axis counts. Electron microscopy-Skeletal muscle was freshly dissected from the quadriceps muscle groups and fixed in 4% Paraformaldehyde and 1 % Glutaraldehyde and secondarily fixed in 1% Osmium Tetraoxide buffered with 0.1 M Phosphate. After washing, the samples were dehydrated sequentially with increasing concentration of ethanol followed by Epon resin infiltration and sections are post stained with Urany acetate and lead citrate. EM imaging was performed at the University of Toronto Imaging Laboratory. Statistical Analysis-Student t-test or MannWhitney non-parametric test were used to compare the group means or medians respectively. A twotailed P value of <0.05 was considered statistically significant.
RESULTS

Diet-induced obesity is attenuated in
LCAT deficient mice in a gender-specific manner. Female Ldlr-/-xLcat-/-mice fed a standard chow diet had a modest but significantly lower body weight compared with their age-matched Ldlr-/-xLcat+/+ mice from as early as five weeks of age. The difference persisted through adult life but the rate of weight gain was similar. (Figure 1a) . Similarly, a small weight difference was also observed in their male counterparts but was no longer present by 10 weeks of age. On the other hand, when these mice were fed the HFHS diet, the Ldlr-/-xLcat-/-mice showed marked attenuation to weight gain when compared with their age-matched Ldlr-/-xLcat+/+ controls. The differences at each age point examined were statistically significant (p < 0.05) for all ages tested in the females and were statistically significant in males from age 13 weeks to 23 weeks, thus more prominent in females (Figure 1b) . The attenuation in diet induced weight gain was more prominent in females than in males. After 10 weeks of HFHS diet, the female Ldlr-/-xLcat-/-mice gained 40 + 11% of body weight compared to a 71 + 21% gain by the male counterpart (p = 0.001). After 20 weeks of HFHS diet feeding, the weight gain in females were still lower than the males but did not reach statistical significance. To test the impact of the background absence of LDL receptor on these metabolic phenotypes, weight gain was also examined in Lcat knockout mice (Lcat-/-) when compared with their age-and gender-matched wild type (WT) controls. When fed a chow diet, Lcat-/-mouse weights did not differ from the WT controls for both male and female (data not shown). However, when fed the HFHS diet, weight gain in the female Lcat-/-mice was markedly attenuated and the difference in weight became statistically significant after 10 weeks on the HFHS diet. In the male Lcat-/-mice, the weight gain remained similar to that in the WT controls (Figure 1c ). To test whether the attenuation of weight gain was related to reduced food intake, we measured mean food intake in both chow-and HFHS-fed LCAT deficient mice and their respective controls. As shown in Figure 1d , Ldlr-/-xLcat-/-mice showed similar mean daily food intake when compared with their Ldlr-/-xLcat+/+ controls, in both males and females. Likewise, food consumption was also similar between Lcat-/-and their WT control mice (data not shown). LCAT deficient mice developed attenuated HFHS diet-induced insulin resistance. We previously reported that Ldlr-/-xLcat-/-mice are more insulin sensitive when compared with the Ldlr-/-xLcat+/+ control on a regular chow diet on the basis of reduced fasting glucose, fasting insulin and improved insulin tolerance test (2, 5) . Here we examined the effect of HFHS-diet on the potential impairment of glucose tolerance. As found on the regular chow diet, the HFHS diet fed female Ldlr-/-xLcat-/-mice maintained a better glucose tolerance in comparison to Ldlr-/-xLcat+/+ females (Figure 2a) . To test whether these protective effects were attributable to LCAT deficiency, we further examined the ipGTT, and ipITT in chow-fed and HFHS diet-fed female Lcat-/-mice vs. their respective age-and gendermatched WT controls. When fed a chow diet, Lcat-/-mice did not reveal insulin hypersensitivity on the basis of an ipITT when compared to the WT littermate controls (data not shown). However, when fed the same HFHS diet, the female Lcat-/-mice showed attenuation to dietinduced insulin resistance on the basis of a greater response during the ITT. After a 6-hour fast, the Lcat-/-mice also showed significantly lower fasting glucose levels. After insulin injection, glucose levels were lower at all time points and reached statistical significance at 120 min ( Figure  2b) . We also observed a trend in improved glucose tolerance in the Lcat-/-mice (Figure 2c ). Taken together, these data suggest that LCAT deficiency confers insulin sensitivity in the presence of metabolic stress, as seen in Lcat-/-mice fed a HFHS diet. Our data also suggest that LDL receptor deficiency per se may also have conferred sufficient metabolic stress to unmask the protective effect of LCAT deficiency even under the chow fed condition. HFHS diet feeding causes accumulation of free cholesterol and phospholipids in VLDL-sized lipid fractions in Ldlr-/-xLcat-/-mice. As shown in Figure 3 , FPLC profile of the HFHS diet treated Ldlr-/-xLcat-/-mice showed marked accumulation of free cholesterol and phospholipids in the largesized fractions. Meanwhile, the hypertriglyceridemia seen the in chow fed Ldlr-/-xLcat-/-mice is no longer present in response to the HFHS diet. Hepatic ER stress UPR markers are up-regulated in chow fed Ldlr-/-xLcat+/+ mice but are normalized in Ldlr-/-xLcat-/-mice. Insulin resistance has been closely associated with and suggested to be caused by ER stress. Thus to further address the mechanism underlying the differential impact of LCAT deficiency on insulin sensitivity and diet-induced weight gain, we examined the role of hepatic ER stress by measuring UPR markers in mice with different genotypes with and without the HFHS treatment. First, we compared baseline hepatic ER stress status by examining mRNA expression levels of Grp78 and CHOP in Ldlr-/-xLcat-/-, Ldlr-/-xLcat++ and wild type under chow fed conditions. We observed a 2.0-fold (p=0.04) up-regulation of mRNA level of Grp78 in 12-week old Ldlr-/-xLcat+/+ mice vs. WT. In Ldlr-/-xLcat-/-mice, the Grp78 mRNA level was reduced by 59.7% when compared with the Ldlr-/-xLcat+/+ mice (p=0.004) and was 0.8-fold vs. WT (p=NS) (Figure 4a ). Similarly hepatic CHOP mRNA was increased 2.0-fold in Ldlr-/-xLcat+/+ mice versus the WT (p=0.04). In Ldlr-/-xLcat-/-mice, there was a 71.5% reduction vs. the Ldlr-/-xLcat+/+ (p=0.004) which was lower but not significantly different from WT, (0.59-fold) (Figure 4b) . In order to test whether diet-induced ER stress may be linked to the observed resistance to dietinduced obesity and insulin resistance, we measured hepatic UPR markers in response to a 36-week treatment of the HFHS diet, beginning at 9-weeks of age. Compared to their chow-fed agematched controls, Ldlr-/-xLcat+/+ mice developed a 2.1-fold (p = 0.005) increase in Grp78 and a 2.32-fold (p = 0.03) increase in CHOP mRNA levels respectively, whereas the Ldlr-/-xLcat-/-showed a non-significant 1.37-fold increase (p = 0.32) in Grp78 and a 1.51-fold increase (p = 0.06) in CHOP (Figure 4c,d) . Consistent with these findings, we also observed a reduction in hepatic phospho-PERK (49% p=0.001) and phospho-eif2α (83% p=0.02) mass in the Ldlr-/-xLcat-/-mice by Western blot (data not shown). Activation of UPR has been shown to be linked to an increase in phosphorylated c-jun which is in turn associated with inhibition of the insulin signaling cascade. We observed an increase in phospho-c-jun in Ldlr-/-xLcat+/+ on HFHS diet when compared with the wild type control but a markedly blunted response in the Ldlr-/-xLcat-/-mice on the diet, in agreement with UPR marker changes (Figure 4e) . LCAT deficient mice have altered adipose tissue mass, reduced adipocyte size and ER stress. Rodents fed high fat diets have been shown to develop enlarged and dysfunctional adipocytes, the latter to include insulin resistance, increased lipolysis and enhanced secretion of proinflammatory cytokines. In chow fed Ldlr-/-xLcat-/-mice, when compared to the age-matched Ldlr-/-xLcat+/+ control, we observed a slight downward shift in cell size distribution albeit the difference in mean adipocyte size was not statistically significant (Figure 5a ). However, when fed a HFHS diet, there was a marked shift in cell size distribution (Figure 5b ) and reduction in mean cell size (Figure 5a ) as well as attenuation in the increase in fat pad weight (Figure 5c ). In female Lcat-/-mice, we observed no difference in fat pad weight and cell size distribution when compared with their WT control. However, after a 20-week HFHS diet, the Lcat-/-mice developed a 26% lower fat pad weight (p = 0.06) (Figure 5d ). We also compared mRNA expressions of UPR markers Grp78 and CHOP in perigonadal fat pads of chow fed female Ldlr-/-xlcat-/-(n=5) vs Ldlr-/-xlcat+/+ (n=4) controls. We observed a 39% reduction in Grp78 mRNA (p = 0.04) and a 31% reduction in CHOP mRNA (p=0.015). Activation of canonical Wnt signaling and suppression of adipogenic genes in adipose tissue. Activation of the canonical Wnt signaling pathway is known to inhibit adipogenesis through activation and nuclear translocation of β-catenin, resulting in the suppression of two critical adipogenic genes, namely PPARγ and C/EBPα. In light of the observed reduction of adipose tissue ER stress in the chow fed Ldlr-/-xLcat-/-mice we hypothesize that adipogenesis is also reduced conjunction with activation of the canonical Wnt signaling pathway. To test this hypothesis, we first observed, in the perigonadal tissue, a 46.5% reduction in C/EBPα mRNA (p < 0.001) and a 35.1% reduction in PPARγ mRNA expression (p = 0.07) (Figure 6a ). To determine whether the canonical Wnt signaling pathway is activated and could account for this suppression, we examined the mRNA levels of other known targets of Wnt signaling. We observed up-regulation of mRNA expression of three β-catenin target genes, axin2 (1.78 fold, p = 0.04), c-myc (2.37 fold, p = 0.03) and cyclinD1 (1.47 fold, p = 0.06) (Figure 6b ). After treatment of the two strains of mice with the HFHS diet, white adipose tissue expression of the Wnt ligand, Wnt10b as well as the β-catenin target gene axin2 remained upregulated in the Ldlr-/-xLcat-/-mice (Figure 6c ).
Activation of skeletal muscle mitochondrial function and uncoupling proteins in Ldlr-/-xLcat-/-mice.
To further characterize the role of skeletal muscle in the altered energy metabolism seen in the LCAT deficient mice, we examined the AMPK/PGC1α/UCP3 axis and the regulation of oxidative phosphorylation genes. In skeletal muscle of overnight fasted mice, Ldlr-/-xLcat-/-mouse skeletal muscle showed a 1.9-fold upregulation of phosphorylation of AMPK (AMPK-pThr 172) (p = 0.04), a marker of AMPK activity (Figure 7a) . We also observed a 1.5-fold upregulation of UCP3 mRNA (p = 0.01), a 3.1-fold upregulation of PGC1α mRNA (p = 0.03), and a 1.9-fold upregulation of Ndufs1 mRNA (p < 0.001), one of the mitochondrial Complex 1 oxidative phosphorylation genes known to be downstream of PGC1α (Figure 7b ). There was also a 1.5-fold upregulation of PGC1α protein content (p = 0.004), Collectively, these changes are remarkably similar to those seen in animals subjected to chronic exercise and are associated with enhanced fatty acid oxidation. In the chow fed Ldlr-/-xLcat-/-mice, we detected an increase in core body temperature when compared with their age-and gender-matched Ldlr-/-xLcat+/+ control (Figure 8a ).
Increased energy expenditure in female Ldlr-/-xLcat-/-mice without increased physical activity.
To test the hypothesis that the protection from diet induced obesity is, at least in part, attributable to increased energy expenditure, by using indirect calorimetry, we showed that the female Ldlr-/-xLcat-/-mice developed a significant 14% increased in mean heat production (Figure 8a ) in the absence of any increase in physical activities (Figure 8b ). These findings are consistent with the observation of increased core temperature (Figure 8c) .
Brown fat cells are present ectopically in skeletal muscle of the Ldlr-/-xLcat-/-mice with high level of UCP1 expression
In light of the significant increase in core temperature and energy expenditure observed in the Ldlr-/-xLcat-/-mice, we hypothesized that excess Ucp1 expression being the underlying cause. We first tested whether the Ldlr-/-xLcat-/-mice developed increase iBAT mass. We compared carefully dissected iBAT pad weights from age-matched female Ldlr-/-xLcat-/-(0.082 + 0.025 gm, n=9) with Ldlr-/-xLcat+/+ (0.098 + 0.020 gm; n=9) and the difference was insignificant (p = 0.1). Likewise, the UCP1 protein mass in the iBAT were also similar between the two groups ( Figure 9 ). To test that excess energy expenditure and heat generation was not due to increased expression of UCP1 in WAT, we measured protein mass of UCP1 in both ingWAT and sWAT depots and did not see a difference in their abundance (Figure 9 ). We then test the hypothesis that UCP1 is expressed ectopically in the skeletal muscle in Ldlr-/-xLcat-/-mice. As seen in Figure 10a , we observed a marked upregulation of Ucp1 mRNA in skeletal muscle of female Ldlr-/-xLcat-/-against its age-and gendermatched Ldlr-/-xLcat+/+ control. Likewise, we also observed a modest upregulation of Ucp1 mRNA in Lcat-/-mice versus their wild type control (Figure 10b ). We also confirmed the marked expression of UCP1 in skeletal muscle of the female Ldlr-/-xLcat-/-mice by Western blotting (Figure10c) . Furthermore, by comparing the expression levels of UCP1 in skeletal muscle and in iBAT, we estimated that the whole body UCP1 abundance in skeletal muscle may be in the order of 20 -30%, basing on the assumption that the ectopic expression of Ucp1 is evenly distributed in skeletal muscle. To further identify the origin of the ectopic UCP1 proteins, we performed immunohistochemical staining and observed positive UCP1 staining localized to islands of cells with brown fat like morphology, namely cells with multiple small fat droplets and prominent central nuclei. These islands were found exclusively between muscle bundles. Electron microscopy of the female Ldlr-/-xLcat-/-quadriceps muscle showed mulitlocular, mitochondrion-rich brown fat cells, verifying the immunohistochemical findings (Figure 11 ). To further support the presence of a development signal for the generation of brown fat cells in the skeletal muscle, we observed marked abundance of PRDM16 protein mass in skeletal muscle of the female Ldlr-/-xLcat-/-mice ( Figure 12 ).
DISCUSSION
In this paper, we observed for the first time that LCAT deficient mice develop a gender-specific protection from HFHS diet-induced obesity and insulin resistance in the absence of hypophagia.
This protective metabolic phenotype is more accentuated in the LDL receptor knockout background and involved multiple metabolic pathways. This is also a first report of ectopic brown adipose tissue expressing high abundance of UCP1 in skeletal muscle of LCAT deficient mice.
Recent studies by Ozcan et al revealed that ER stress plays a crucial role in the development of both diet-induced and genetic hypertrophic obesity and its associated metabolic complications, namely insulin resistance (6) . In this experimental paradigm, excess caloric intakeinduced hypertrophic obesity is linked to activation of a number of the UPR pathways as characterized by upregulation of mRNA levels of the chaperone Grp78 as well as CHOP and these changes correlated well with enhanced hepatic levels of phospho-PERK and phospho-eIF2α. Furthermore, an upregulation of phospho-c-jun was linked to impairment of the insulin signaling cascade in the liver (6), providing further evidence that ER stress may play an important role in the development of insulin resistance in both dietinduced and genetic models of obesity. In these mocdels, activation of UPR is also detected in white adipose tissues. Intriguingly, treatment with phenylbutyrate (PBA), a chemical chaperone, in ob/ob mice led to a rapid and dramatic resolution of insulin resistance in conjunction with normalization of the UPR markers (7), changes in disproportion to the weight change. On a chow diet, we observed a 2-fold upregulation of hepatic mRNA levels of Grp78 and CHOP in the Ldlr-/-xLcat+/+ mice when compared to age-and gender-matched C57Bl/6 wild type (WT) mice, suggestive of an endogenous basal elevation of the UPR. Although the mechanism for the increased UPR marker expressions in Ldlr-/-xLcat+/+ mice is not known, these findings are consistent with, and may indeed explain, the previous observation that LDL receptor knockout mice (C57Bl/6 background) developed more severe diet-induced metabolic phenotypes including adiposity and insulin resistance than their C57Bl/6 wild type controls (29) . Conceivably, the increased ER stress in the Ldlr-/-xLcat+/+ mice may have provided a basal chronic metabolic stress over which the protective effect of LCAT was unmasked. Our observation of the normalization of Grp78 and CHOP mRNA levels in the Ldlr-/-xLcat-/-mice and the associated reduction in hepatic phospho-cjun level are therefore consistent with the previously reported enhanced insulin sensitivity seen in these mice (5) . In chow fed Ldlr-/-xLcat-/-mice, the adipose tissue UPR markers were also reduced when compared with the Ldlr-/-xLcat+/+ controls, in agreement with the changes seen in the liver.
The reduction in the expression of UPR markers and their metabolic impact seen in the Ldlr-/-xLcat-/-mice persisted even when the mice were challenged with a long term HFHS diet, as shown in Figure 4 . As expected, the UPR markers were markedly increased in the Ldlr-/-xLcat+/+ control mice on the HFHS diet when compared with their chow fed controls. On the other hand, the fold increase in UPR markers in response to the same diet was significantly lower in the ageand gender-matched Ldlr-/-xLcat-/-mice. Furthermore, Grp78 and CHOP mRNA levels in the HFHS diet-treated Ldlr-/-xLcat-/-mice were significantly lower than the Ldlr-/-xLcat+/+ controls at 54 weeks. These findings of reduction in the UPR were further substantiated by significant reductions in hepatic phospho-PERK and phospho-eIF2α levels by Western blot.
In addition to the important role of the adipose tissue UPR in insulin sensitivity, the biological significance of a reduction in UPR in the adipose tissue may include alteration of adipogenicity. A recent study by Basseri et al suggests that resolution of UPR in adipose tissue in response to PBA treatment causes inhibition of adipogenesis (12) . Our findings of concomitant reductions in the adipose tissue adipogenesis genes, PPARγ and C/EBPα, in association with a reduction in UPR markers in the Ldlr-/-xLcat-/-mice is consistent with this notion. Furthermore, we also observed concomitant upregulation of axin2, c-myc and cyclinD1, three of the wellestablished target genes of β-catenin, suggestive of activation of canonical Wnt signaling. As Wnt signaling has long been recognized to inhibit adipogenesis, our observed upregulation of adipose tissue β-catenin activation may serve as a causal link to the downregulation of adipogenic genes. After prolonged HFHS diet treatment, we observed persistence of up-regulation of axin2 in the adipose tissue, suggestive of persistent activation of Wnt signaling under the dietary stress. Previous studies revealed that constitutive, adipose tissue specific overexpression of Wnt10b, a Wnt ligand highly expressed in the stromovascular fraction, including preadipocytes, resulted in resistance to diet induced obesity and insulin resistance (30, 31) . In this transgenic model, the authors reported significant reduction in adult adipose tissue expression of both C/EBPα and PPARγ genes. In HFHS-diet fed Ldlr-/-xLcat-/-mouse adipose tissue, Wnt10b expression was significantly elevated (Figure 7c ), consistent with a role of activated Wnt signaling in LCAT deficient mouse adipose tissue. The question of whether the decrease in the UPR in the Ldlr-/-xLcat-/-mouse adipose tissue contributed to the activation of Wnt signaling requires further investigations.
In light of the observations of increased core temperature and energy expenditure in the Ldlr-/-xLcat-/-mice, we hypothesized excess UCP1 expression as a potential cause. We systematically excluded the scenario of excess UCP1 expressed in brown (iBAT) and specific inducible white adipose depots (sWAT and ingWAT). We have identified marked excess of UCP1 expression at both the protein and mRNA levels in skeletal muscle of Ldlr-/-xLcat-/-mice. We also observed a more modest degree of upregulation of Ucp1 in the female Lcat-/-mice, thus suggesting that the ectopic expression is attributable to LCAT deficiency per se and absence of LDL receptor strongly augments this ectopic expression. As PRDM16 has been shown to function as a key molecular switch to induce brown fat development from Myf5 positive myoblastic progenitor cells (22) , the observation of increased skeletal muscle PRDM16 protein abundance support the notion that the ectopic brown adipose tissue develops, through activation of PRDM16, from the myoblatic lineage. However, lineage tracing study is required to provide definitive proof.
By comparing the UCP1 protein abundance in the quadriceps muscle and that in the iBAT, assuming that these islands of brown fat are distributed evenly throughout the musculature, we estimated that the whole body UCP1 present in the Ldlr-/-xLcat-/-mouse skeletal muscle being in the order of 20 -30%. Since transgenic models overexpressing the Ucp1 gene in skeletal muscle and adipose tissue have all been shown to confer metabolically favorable phenotypes, including improved insulin sensitivity, reduced white fat mass and liver mass, improved skeletal muscle AMPK activities, ameliorates oxidative stress and glucose substrate utilization (32, 33) . Furthermore, it has been suggested that ectopic expression of Ucp1 at as little as 10% that of the iBAT is sufficient to confer metabolic benefits (32) . We therefore expect that Ucp1 expression in the ectopic brown fat in the LCAT deficient mice will also be functionally active.
In addition to the ectopic expression of brown fat and UCP1, the Ldlr-/-xLcat-/-mice also showed increased expression in the skeletal muscle of a panel of genes which includes UCP3, PGC1α, NDUFS1 in association with elevated level of p172Thr-AMPK, the active form of AMPK.
Uncoupling protein 3 (UCP3), a member of the mitochondrial anion carrier protein family which is highly expressed and selectively in skeletal muscle, has been implicated in facilitating fatty acid transport and oxidation as characterized by (1) increased fatty acid translocase (FAT/CD36) expression, (2) upregulation of activities of carnitine palmitoyltransferase I (CPT1), 3-hydroxyacyl-CoA dehydrogenase (β-HAD), citrate synthase (CS) and increased expression of mitochondrial thioesterase 1 (MTE-1) (18, 19) . PGC1α has been shown to play critical roles in (a) stimulating thermogenesis; (b) activating genes in oxidative phosphorylation (13); (c) stimulate mitochondrial biogenesis through coactivation of nuclear respiratory factor-1 (NRF-1) and (d) activating GLUT4 expression through coactivating MEF2C (13) . In humans, elevated expression of skeletal muscle PGC1α has been seen in response to (i) acute endurance exercise and (ii) chronically trained muscle (34) . Pathophysiologically, skeletal muscle PGC1α mRNA expression is down-regulated along with a panel of genes in mitochondrial oxidative phosphorylation in humans with IR or diabetes (14) as well as in rodent models of obesity, IR and/or diabetes, (15, 16) . In skeletal muscle, activated AMPK acts directly to phosphorylate and activate PGC1α on Thr-177 and Ser-538 (35) . Taken together, these metabolic changes in the skeletal muscle of Ldlr-/-xLcat-/-mice suggest enhanced β-oxidation (UCP3) and mitochondria oxidative phosphorylation, the latter as evidenced by the observed upregulation of Ndusf1. The mechanistic link between enzymatic action of LCAT and the metabolic phenotypes reported here is not known. LCAT deficiency is associated with a complex dyslipidemic phenotype. The changes in the FPLC profile of the Ldlr-/-xLcat-/-mice fed a HFHS diet is unique. Most notable is the dissolution of VLDL in the chow fed mice but the appearance of the large sized, free cholesterol and phospholipid-enriched lipid fractions, resembling LpX (36) . However, further studies are required to elucidate the potential significance these circulating lipid changes in the observed protection from dietinduced obesity.
In summary, in this study, we have extended the analysis of the metabolic phenotypes of LCAT deficient mice. We found enhanced insulin sensitivity and resistance to diet-induced obesity manifested in a gender-specific manner. These protective phenotypes have been linked to protection against diet-induced hepatic and adipocytes ER stress. We are also the first to report ectopic expression of UCP1, residing in brown adipose tissues embedded in the interfiber regions of the skeletal muscle in the Ldlr-/-xLcat-/-mice. These findings are likely the explanation for the observed increase in energy expenditure and higher core temperature. Further work is require to elucidate the cellular origin of the ectopic brown fat, and the mechanism by which LCAT deficiency evokes the ectopic expressions. 
